These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 16904536

  • 1. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
    McCullough PA, Bertrand ME, Brinker JA, Stacul F.
    J Am Coll Cardiol; 2006 Aug 15; 48(4):692-9. PubMed ID: 16904536
    [Abstract] [Full Text] [Related]

  • 2. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
    Heinrich MC, Häberle L, Müller V, Bautz W, Uder M.
    Radiology; 2009 Jan 15; 250(1):68-86. PubMed ID: 19092091
    [Abstract] [Full Text] [Related]

  • 3. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS.
    JACC Cardiovasc Interv; 2009 Jul 15; 2(7):645-54. PubMed ID: 19628188
    [Abstract] [Full Text] [Related]

  • 4. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):958-65. PubMed ID: 19021282
    [Abstract] [Full Text] [Related]

  • 5. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):924-30. PubMed ID: 16949481
    [Abstract] [Full Text] [Related]

  • 6. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
    Serafin Z, Karolkiewicz M, Gruszka M, Strózecki P, Lasek W, Odrowaz-Sypniewska G, Manitius J, Beuth W.
    Acta Radiol; 2011 May 01; 52(4):422-9. PubMed ID: 21498279
    [Abstract] [Full Text] [Related]

  • 7. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD.
    JACC Cardiovasc Interv; 2009 May 01; 2(5):415-21. PubMed ID: 19463464
    [Abstract] [Full Text] [Related]

  • 8. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
    From AM, Al Badarin FJ, McDonald FS, Bartholmai BJ, Cha SS, Rihal CS.
    Circ Cardiovasc Interv; 2010 Aug 01; 3(4):351-8. PubMed ID: 20647563
    [Abstract] [Full Text] [Related]

  • 9. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
    Zhang BC, Wu Q, Wang C, Li DY, Wang ZR.
    J Cardiol; 2014 Apr 01; 63(4):260-8. PubMed ID: 24397991
    [Abstract] [Full Text] [Related]

  • 10. Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: A meta-analysis of full-text prospective, randomized controlled trials.
    Han XF, Zhang XX, Liu KM, Tan H, Zhang Q.
    PLoS One; 2018 Apr 01; 13(3):e0194330. PubMed ID: 29558481
    [Abstract] [Full Text] [Related]

  • 11. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
    Eng J, Wilson RF, Subramaniam RM, Zhang A, Suarez-Cuervo C, Turban S, Choi MJ, Sherrod C, Hutfless S, Iyoha EE, Bass EB.
    Ann Intern Med; 2016 Mar 15; 164(6):417-24. PubMed ID: 26830055
    [Abstract] [Full Text] [Related]

  • 12. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
    Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF, VALOR Trial Investigators.
    Am Heart J; 2008 Oct 15; 156(4):776-82. PubMed ID: 18946896
    [Abstract] [Full Text] [Related]

  • 13. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH.
    Am J Cardiol; 2011 Jul 15; 108(2):189-94. PubMed ID: 21545991
    [Abstract] [Full Text] [Related]

  • 14. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE, Investigators of the CARE Study.
    Circulation; 2007 Jun 26; 115(25):3189-96. PubMed ID: 17562951
    [Abstract] [Full Text] [Related]

  • 15. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
    Thomsen HS, Morcos SK.
    Eur Radiol; 2009 Apr 26; 19(4):891-7. PubMed ID: 19002467
    [Abstract] [Full Text] [Related]

  • 16. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
    From AM, Bartholmai BJ, Williams AW, McDonald FS.
    Acta Radiol; 2008 May 26; 49(4):409-14. PubMed ID: 18415784
    [Abstract] [Full Text] [Related]

  • 17. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
    Feldkamp T, Baumgart D, Elsner M, Herget-Rosenthal S, Pietruck F, Erbel R, Philipp T, Kribben A.
    Clin Nephrol; 2006 Nov 26; 66(5):322-30. PubMed ID: 17140161
    [Abstract] [Full Text] [Related]

  • 18. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators.
    N Engl J Med; 2003 Feb 06; 348(6):491-9. PubMed ID: 12571256
    [Abstract] [Full Text] [Related]

  • 19. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP, Winter JP, Nguyen-Do P, Lo S, French JK, Hallani H, Fernandes C, Jepson N, Leung DY.
    Intern Med J; 2009 Jan 06; 39(1):25-31. PubMed ID: 18771430
    [Abstract] [Full Text] [Related]

  • 20. Recent clinical trials of iodixanol.
    Erdogan A, Davidson CJ.
    Rev Cardiovasc Med; 2003 Jan 06; 4 Suppl 5():S43-50. PubMed ID: 14668709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.